REVELAC-i Influenza Vaccine effectiveness Report – mid-season 2026

Mid-season results from the REVELAC-i network show that influenza vaccination reduced the risk of influenza-related hospitalization by 37% across six countries in Latin America and the Caribbean during the 2026 Southern Hemisphere season. The findings reinforce the value of seasonal influenza vaccination in protecting people at higher risk of severe illness.